Search Results

Your search matched 38 results

  • 1
  • 2
#1

Peer To Peer Insights in the COVID-19 Era and Beyond | Perspectives

COVID-19 has introduced an era of unprecedented events to industries across the globe.

#2

P2P Networks Huge for COVID-19 Patients, Responders | Blog

Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.

#3

Adapt, Don’t Cancel: How to Go Virtual When Attendees Can’t Travel | Perspectives

Virtual delivery requires you to rethink your content and approaches.

#4

PHARMA TRENDS 2020—2025: Four Headwinds Driving Healthcare Transformation — and What We’re Doing | Blog

How COVID-19 and 3 other barriers will transform healthcare over the next few years.

#5

Four Critical Dynamics for Virtual Collaboration | Blog

Achieving success in the current global context now hinges on “the virtual meeting” – the most important method for teams to stay connected, troubleshoot, and drive results.

#6

Contingency 2020: Four Strategic Ways to Maintain Momentum Through Disruption | Perspectives

Four Rapid Response Approaches To Maintain Business Momentum

#7

How Health Tech is Helping Countries Around the World Tackle Coronavirus | Blog

With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.

#8

Leading Through Uncertainty Amidst the Global Pandemic | Perspectives

Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.

#9

The Syneos Health Podcast, Coronavirus Special Edition: The Personal Experience | Perspectives

The COVID-19 (coronavirus) outbreak continues to grow worldwide – recently declared by the World Health Organization as a global pandemic – with widespread personal, medical, and business implications.

#10

Meet Think Bank | Perspectives

Think Bank is an agile way to answer complex questions.

#11

The Syneos Health Podcast, Coronavirus Special Edition: Payers and COVID-19 | Perspectives

In this Coronavirus Special Edition Series, we’ve talked a lot about the clinical implications of the COVID-19 pandemic.

#12

Life Sciences Commercialization in the COVID-19 Era: Critical Pivot Points to Mitigate Risk | Perspectives

Learn how to pivot and adapt your commercialization and communications tactics amid COVID-19 with insights from Rich Gorman and Leigh Householder at Syneos Health in this Xtalks webinar.

#13

Israel Gets Head Start in Race for COVID-19 Vaccine | Blog

For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.

#14

Pivot Past the Pandemic | Perspectives

Life sciences commercialization in the COVID-19 era and beyond

#15

2020 Employee Communications and Behavioral Science Contingency | Perspectives

Recommendations for activities to inform and engage

#16

COVID-19: Optimizing Promotions with HCP Preferences | Perspectives

Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.

#17

Best Practices: Social Media Content and Activity During COVID-19 | Perspectives

In this PM360 article, Steve Marino, Managing Director of Digital & Social Strategy at Syneos Health Communications, shares "guidance (that) can help marketers navigate their way as they make decisions about what types of content to post, and what not to post."

#18

Demonstrating Value in the Real World | Perspectives

Life sciences companies have a variety of tools to demonstrate the value of their medicines in the real world, but any innovative agreement or study should definitively answer these five questions.

#19

MM&M eBook: Marketing in a Crisis | In The Media

In the "Marketing in a Crisis" eBook by MM&M, Scott Page of GSW, a Syneos Health company, says: “We are in this business of healthcare because it is a higher calling."

#20

Clearing a Commercial Path for Novel Cancer Therapeutics in a Post-Pandemic World | Perspectives

Part I of a Syneos Health Series on New Oncology Commercialization Strategies

#21

It's Time for a Digital Reset | Perspectives

What should the evolution of your digital strategy look like through COVID-19 and beyond?

#22

It’s Time to Rethink How Pharma Can Unleash the Potential of AI | Perspectives

The response to COVID-19 has brought into sharp focus the need for greater efficiencies in drug discovery and development.

#23

There’s a Looming Mental Health Crisis but Tech is Here to Help | Blog

The COVID-19 pandemic is steadily increasing our risk for a mental health crisis around the world.

#24

COVID vaccine deemed essential to re-opening activities—But, no-thanks, it’s not for me! | Blog

With the dramatic impact that COVID 19 has had on work, school, social engagements, and overall life as we know it, one would think that people would be anxious to be vaccinated.

#25

Payer Priorities in a Pandemic | In The Media

What are payers focused on during the COVID-19 pandemic?

#26

Here are a Few Changes We Can Expect to See in Our World After COVID | Blog

COVID-19 has accelerated the rate at which we’re seeing change happening around us.

#27

Is Your Mask Up to the Task? | Blog

Deciding when, where, and what mask to wear has been a large topic of discussion as we re-enter into the “New Normal.”

#28

Clear, Consistent Healthcare Communication: Lessons from COVID-19 | Blog

Patients are often at risk when presented with mixed messages.

#29

As Moods Shift Around COVID, Pharma Makes New Social Plans | Blog

As some people near the end of their third month of lockdown, many COVID-19-related trends are starting to look quite different than they did toward the beginning of the pandemic.

#30

Telemedicine Use and Field Force Engagement in the COVID-19 Era and Beyond | Perspectives

As we continue to navigate these unprecedented times, Syneos Health conducted two surveys during the months of March and May to help us track and understand the impact COVID-19 has had on physicians’ engagement with telemedicine platforms and field force teams.

  • 1
  • 2